• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞-淋巴细胞比值对接受新辅助放化疗的局部晚期直肠癌患者肿瘤退缩分级和预后的预测价值。

Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.

机构信息

National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, P.R. China.

出版信息

Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231202611. doi: 10.1177/15330338231202611.

DOI:10.1177/15330338231202611
PMID:37807729
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10563499/
Abstract

PURPOSE

Numerous indicators can be used to predict tumor patients' prognosis and tumor regression grade (TRG). The role of the neutrophil-lymphocyte ratio (NLR) among individuals with locally advanced rectal cancer (LARC) following neoadjuvant chemoradiotherapy (nCRT) hasn't been studied, nevertheless. This study aims to explore the predictive value of the NLR before nCRT (pre-NLR) in TRG and prognosis of LARC patients undergoing nCRT..

METHODS

In this retrospective investigation, 326 LARC patients receiving nCRT in total were included. The link between the pre-NLR and TRG was examined using a logistic regression analysis. A Cox-based nomogram was created in the meanwhile to forecast overall survival (OS). With the use of calibration plots and receiver operating characteristic (ROC) curves, we evaluated the nomogram's predictive capabilities.

RESULTS

The median pre-NLR across 326 patients was 2.2 (interquartile range, IQR: 1.7-2.7). In the logistic regression analysis, only the pre-NLR for TRG in LARC patients receiving nCRT was statistically significant (odds ratio, OR = 0.62, 95% CI: 0.47-0.80, P < 0.001). Pre-NLR, nCRT with surgery interval, ypTNM stage, TRG, vascular invasion, adjuvant chemotherapy, and carbohydrate antigen 19-9 before nCRT were revealed to be OS predictors in the Cox multivariate analysis. According to calibration plots and ROC curves, the predictive nomogram demonstrated high statistical performance on internal validation.

CONCLUSION

This study demonstrated that a lower pre-NLR was probably associated with a greater rate of TRG in LARC patients undergoing nCRT. Furthermore, the pre-NLR was credibly correlated with OS in LARC patients undergoing nCRT. Meanwhile, we constructed a nomogram for predicting the prognosis in LARC patients undergoing nCRT.

摘要

目的

有许多指标可用于预测肿瘤患者的预后和肿瘤退缩分级(TRG)。然而,新辅助放化疗(nCRT)后局部晚期直肠癌(LARC)患者中性粒细胞-淋巴细胞比值(NLR)的作用尚未得到研究。本研究旨在探讨 nCRT 前 NLR(pre-NLR)与接受 nCRT 的 LARC 患者 TRG 和预后的关系。

方法

本回顾性研究共纳入 326 例接受 nCRT 的 LARC 患者。采用 logistic 回归分析探讨 pre-NLR 与 TRG 的关系。同时,基于 Cox 建立nomogram 预测总生存(OS)。通过校准图和接受者操作特征(ROC)曲线评估 nomogram 的预测能力。

结果

326 例患者的中位 pre-NLR 为 2.2(四分位距,IQR:1.7-2.7)。logistic 回归分析显示,仅 nCRT 后 LARC 患者的 pre-NLR 与 TRG 相关(比值比,OR=0.62,95%可信区间:0.47-0.80,P<0.001)。Cox 多因素分析显示,pre-NLR、nCRT 与手术间隔时间、ypTNM 分期、TRG、血管侵犯、辅助化疗和 nCRT 前 CA19-9 是 OS 的预测因素。根据校准图和 ROC 曲线,内部验证显示预测 nomogram 具有较高的统计学性能。

结论

本研究表明,nCRT 后 LARC 患者较低的 pre-NLR 可能与更高的 TRG 率相关。此外,pre-NLR 与 nCRT 后 LARC 患者的 OS 显著相关。同时,我们构建了一个预测 nCRT 后 LARC 患者预后的 nomogram。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a655/10563499/681a48f3960d/10.1177_15330338231202611-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a655/10563499/fae4c74b41b8/10.1177_15330338231202611-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a655/10563499/103afb8e421b/10.1177_15330338231202611-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a655/10563499/5593d6fa3786/10.1177_15330338231202611-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a655/10563499/681a48f3960d/10.1177_15330338231202611-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a655/10563499/fae4c74b41b8/10.1177_15330338231202611-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a655/10563499/103afb8e421b/10.1177_15330338231202611-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a655/10563499/5593d6fa3786/10.1177_15330338231202611-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a655/10563499/681a48f3960d/10.1177_15330338231202611-fig4.jpg

相似文献

1
Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.中性粒细胞-淋巴细胞比值对接受新辅助放化疗的局部晚期直肠癌患者肿瘤退缩分级和预后的预测价值。
Technol Cancer Res Treat. 2023 Jan-Dec;22:15330338231202611. doi: 10.1177/15330338231202611.
2
Predictive value of indirect bilirubin before neoadjuvant chemoradiotherapy in evaluating prognosis of local advanced rectal cancer patients.新辅助放化疗前间接胆红素对局部晚期直肠癌患者预后评估的预测价值
World J Gastrointest Oncol. 2022 Nov 15;14(11):2224-2237. doi: 10.4251/wjgo.v14.i11.2224.
3
Development of clinical inflammatory models to predict the efficacy of neoadjuvant chemoradiotherapy and survival in patients with locally advanced rectal cancer: a retrospective study.开发临床炎症模型以预测局部晚期直肠癌患者新辅助放化疗的疗效和生存:一项回顾性研究
Int J Colorectal Dis. 2025 Apr 14;40(1):92. doi: 10.1007/s00384-025-04875-0.
4
Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio as Prognostic Factors in Locally Advanced Rectal Cancer.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值作为局部晚期直肠癌的预后因素。
Oncology. 2023;101(6):349-357. doi: 10.1159/000526450. Epub 2022 Oct 21.
5
Prognostic value of mesorectal package area in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A retrospective cohort study.新辅助放化疗后局部晚期直肠癌患者中直肠系膜包绕面积的预后价值:一项回顾性队列研究
Front Oncol. 2022 Oct 3;12:941786. doi: 10.3389/fonc.2022.941786. eCollection 2022.
6
Evaluation of Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio on Predicting Responsiveness to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients.中性粒细胞-淋巴细胞比值和血小板-淋巴细胞比值对局部晚期直肠癌患者新辅助放化疗反应性的预测评估。
Biomed Res Int. 2022 Sep 28;2022:3839670. doi: 10.1155/2022/3839670. eCollection 2022.
7
Lymph Node Regression to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer: Prognostic Implication and a Predictive Model.局部进展期直肠癌新辅助放化疗后淋巴结退缩:预后意义和预测模型。
J Gastrointest Surg. 2021 Apr;25(4):1019-1028. doi: 10.1007/s11605-020-04566-x. Epub 2020 Mar 26.
8
Neutrophil-to-Lymphocyte Ratio (NLR) as a Poor Predictive Biomarker for Pathological Response to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Prospective Study.中性粒细胞与淋巴细胞比值(NLR)作为局部晚期直肠癌新辅助放化疗病理反应不良预测生物标志物的前瞻性研究。
Asian Pac J Cancer Prev. 2023 Jan 1;24(1):61-67. doi: 10.31557/APJCP.2023.24.1.61.
9
Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as predictive and prognostic markers in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiation.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值作为接受新辅助放化疗的局部晚期直肠癌患者的预测和预后标志物。
BMC Cancer. 2019 Jul 5;19(1):664. doi: 10.1186/s12885-019-5892-x.
10
An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.基于炎症指数预测直肠黏液腺癌新辅助放化疗的治疗反应。
Int J Clin Oncol. 2020 Jul;25(7):1299-1307. doi: 10.1007/s10147-020-01670-5. Epub 2020 Apr 9.

引用本文的文献

1
Evaluation of pre-treatment F-18 FDG PET/CT according to Mandard classification in locally advanced rectal cancer patients undergoing neoadjuvant chemoradiotherapy.根据曼德尔分类法对接受新辅助放化疗的局部晚期直肠癌患者进行治疗前F-18 FDG PET/CT评估。
BMC Cancer. 2025 Aug 4;25(1):1262. doi: 10.1186/s12885-025-14659-y.
2
Predictive value of a nomogram model for treatment response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer.列线图模型对局部晚期直肠癌新辅助放化疗治疗反应的预测价值
World J Gastrointest Oncol. 2025 Jul 15;17(7):105403. doi: 10.4251/wjgo.v17.i7.105403.
3
Smoking and Elevated Preneoadjuvant Chemoradiotherapy Serum Carcinoembryonic Antigen Levels Are Associated With High Tumor Regression Grade and Poor Survival in Patients With Locally Advanced Rectal Cancer.

本文引用的文献

1
The Preoperative Neutrophil Lymphocyte Ratio and Platelet Lymphocyte Ratio Predicts Disease-Free Survival in Resectable Esophageal Squamous Cell Carcinoma.术前中性粒细胞淋巴细胞比值和血小板淋巴细胞比值可预测可切除食管鳞状细胞癌的无病生存期。
Cancer Manag Res. 2021 Oct 1;13:7511-7516. doi: 10.2147/CMAR.S321326. eCollection 2021.
2
Neutrophil-Lymphocyte Ratio and Circulating Tumor Cells Counts Predict Prognosis in Gastrointestinal Cancer Patients.中性粒细胞与淋巴细胞比值及循环肿瘤细胞计数可预测胃肠道癌患者的预后。
Front Oncol. 2021 Jul 7;11:710704. doi: 10.3389/fonc.2021.710704. eCollection 2021.
3
Systemic Immune-inflammation Index (SII) Predicts Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
吸烟和新辅助放化疗前血清癌胚抗原水平升高与局部晚期直肠癌患者的高肿瘤退缩分级及不良生存相关。
Kaohsiung J Med Sci. 2025 Jun;41(6):e70008. doi: 10.1002/kjm2.70008. Epub 2025 Mar 13.
4
The Prognostic Value of Tumor-Associated Neutrophils in Colorectal Cancer: A Systematic Review and Meta-Analysis.肿瘤相关中性粒细胞在结直肠癌中的预后价值:一项系统评价和荟萃分析
Cancer Med. 2025 Mar;14(5):e70614. doi: 10.1002/cam4.70614.
5
Neutrophil-to-lymphocyte ratio in type 2 diabetes patients combined with Lower Extremity Peripheral Artery Disease.2型糖尿病合并下肢外周动脉疾病患者的中性粒细胞与淋巴细胞比值
Front Endocrinol (Lausanne). 2024 Aug 30;15:1434580. doi: 10.3389/fendo.2024.1434580. eCollection 2024.
全身免疫炎症指数(SII)预测局部晚期直肠癌新辅助放化疗后的病理完全缓解情况。
J Coll Physicians Surg Pak. 2021 Apr;31(4):399-404. doi: 10.29271/jcpsp.2021.04.399.
4
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.《全球癌症统计数据 2020:全球 185 个国家和地区 36 种癌症的发病率和死亡率估计》。
CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4.
5
Preoperative plus postoperative neutrophil-lymphocyte ratio for predicting overall survival following partial hepatectomy for hepatocellular carcinoma.术前加术后中性粒细胞与淋巴细胞比值对预测肝细胞癌肝部分切除术后总生存期的价值
Oncol Lett. 2020 Dec;20(6):375. doi: 10.3892/ol.2020.12238. Epub 2020 Oct 21.
6
BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy.体重指数可能是接受长期新辅助放化疗的局部晚期直肠癌患者的一个预后因素。
Cancer Manag Res. 2020 Oct 20;12:10321-10332. doi: 10.2147/CMAR.S268928. eCollection 2020.
7
Predictive significance of cancer related-inflammatory markers in locally advanced rectal cancer.癌症相关炎症标志物在局部晚期直肠癌中的预测意义
World J Gastrointest Surg. 2020 Sep 27;12(9):390-396. doi: 10.4240/wjgs.v12.i9.390.
8
Systemic inflammatory indices predict tumor response to neoadjuvant chemoradiotherapy for locally advanced rectal cancer.全身炎症指标可预测局部晚期直肠癌对新辅助放化疗的肿瘤反应。
Oncol Lett. 2020 Sep;20(3):2763-2770. doi: 10.3892/ol.2020.11812. Epub 2020 Jul 3.
9
NCCN Guidelines Insights: Rectal Cancer, Version 6.2020.NCCN 指南解读:直肠癌,第 6 版,2020 年。
J Natl Compr Canc Netw. 2020 Jul;18(7):806-815. doi: 10.6004/jnccn.2020.0032.
10
An inflammation index-based prediction of treatment response to neoadjuvant chemoradiotherapy for rectal mucinous adenocarcinoma.基于炎症指数预测直肠黏液腺癌新辅助放化疗的治疗反应。
Int J Clin Oncol. 2020 Jul;25(7):1299-1307. doi: 10.1007/s10147-020-01670-5. Epub 2020 Apr 9.